Free Trial

TD Securities Reiterates "C$13.00" Price Target for Vitalhub (TSE:VHI)

Vitalhub logo with Medical background

Vitalhub (TSE:VHI - Get Free Report) has been given a C$13.00 price objective by equities research analysts at TD Securities in a note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has a "buy" rating on the stock. TD Securities' price target suggests a potential upside of 19.93% from the stock's previous close.

Separately, Cormark increased their price target on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a "buy" rating in a research note on Wednesday, October 2nd.

Read Our Latest Research Report on Vitalhub

Vitalhub Stock Up 5.8 %

VHI stock traded up C$0.59 during midday trading on Friday, reaching C$10.84. 180,900 shares of the company's stock traded hands, compared to its average volume of 123,989. The company has a 50-day simple moving average of C$9.60 and a two-hundred day simple moving average of C$8.26. Vitalhub has a 1-year low of C$3.69 and a 1-year high of C$11.50. The company has a market cap of C$551.21 million, a price-to-earnings ratio of 98.55, a PEG ratio of 1.18 and a beta of 1.26.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Featured Stories

Should you invest $1,000 in Vitalhub right now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines